Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-04-11)Premium Content

Bristol Myers Squibb Co (BMY)

2014-04-23@09:57:15 ET
Global T-Cell Leukemia Therapeutics Pipeline Review 2014 - Analysis of 10 Companies & 14 Drug Profiles (MTO)

2014-04-23@08:50:48 ET
Bristol Myers (BMY) Showing Neutral Technicals With Support At $49.76 (FBM)

2014-04-23@07:30:57 ET
Peregrine Pharmaceuticals Announces Initiation of an Investigator-Sponsored Trial Combining Its Immunotherapy Bavituximab and Ipilimumab (Yervoy(R)) in Advanced Melanoma (INW)

2014-04-23@06:47:53 ET
Bristol-Myers expands manufacturing agreement with Samsung BioLogics (DTM)

2014-04-23@05:13:37 ET
Bristol-Myers Squibb expands manufacturing agreement with Samsung BioLogics (MTO)

2014-04-22@16:26:01 ET
Potential Bristol Myers (BMY) Trade Has 5.27% Downside Protection (FBM)

2014-04-22@06:30:07 ET
Global Synthetic Biology Market 2013-2019 - Genome Engineering, DNA Sequencing, Bioinformatics & Biological Components and Integrated Systems (MTO)

2014-04-21@17:13:57 ET
SmarTrend Watching for Potential Pullback in Shares of Bristol-Myers Squibb After 2.12% Gain (PSM)

2014-04-21@17:13:26 ET
Look for Shares of Bristol-Myers Squibb to Potentially Pullback after Yesterday's 2.12% Rise (PSM)

2014-04-21@12:44:56 ET
Bristol-Myers Squibb (BMY) Breaks Through Resistance at $49.78 (PSM)

2014-04-21@12:39:22 ET
Bristol Myers (BMY) Showing Bearish Technicals With Support At $48.63 (FBM)

2014-04-21@10:34:52 ET
Bristol-Myers Squibb (BMY) Approaches New Upside Target of $50.09 (F79)

2014-04-18@00:59:11 ET
FluoroPharma Names Dr. H. William Strauss to Chair the Scientific Advisory Board (CLM)

2014-04-17@12:02:03 ET
Bristol-Myers Squibb Bullish Moving Average Crossover Alert (BMY) (F78)

2014-04-17@11:30:00 ET
Surveyed U.S. Physicians Expect Strong Uptake of Novel Oral Anticoagulants for the Treatment of VTE (PRN)

2014-04-17@00:36:00 ET
Bristol-Myers Squibb Reports Submission of New Drug Application to U.S. FDA for a Fixed-Dose Combination Tablet of Atazanavir Sulfate with Cobicistat for People Living with HIV-1 (CLM)

2014-04-16@13:28:23 ET
Bristol-Myers Squibb (BMY) Breaks Through Resistance at $48.61 (F79)

2014-04-16@12:42:24 ET
Shares of Bristol-Myers Squibb Receive a Boost, Up 1.3% (F77)

2014-04-16@11:14:57 ET
Bristol-Myers Squibb (BMY) Crosses Pivot Point Resistance at $48.61 (PSM)

2014-04-16@07:11:09 ET
Bristol-Myers Seeks Approval for HIV Combo Drug (ZAX)